文献速递细菌感染、耐药与抗菌药物医院感染防控

人工智能与感染性疾病:应对抗菌药物耐药,从个体化诊疗到抗生素研发

Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery.
PubMed 文献 · Lancet Infect Dis · 2025-09-16

抗菌药物耐药(AMR)是棘手问题,联合国大会高级别声明设定了人类、动物和环境健康的目标。本文综述人工智能(AI)在药物研发、抗菌药物管理、诊断和监测等领域的应用潜力,并讨论技术、基础设施、监管、伦理和政策挑战。

要点

  • AI可揭示数据中临床难以识别的模式,支持临床决策系统助力实现UNGA目标。
  • AI在AMR应对中的潜在应用包括药物发现与开发、抗菌药物管理、诊断和监测。
  • 实施AI面临基础设施、专业知识和监管伦理政策等多重障碍。

核心结论

  • AI在应对AMR方面具有潜力,但基础设施、专业知识和实施障碍仍需解决。

研究设计与样本

  • 本文为系列综述,讨论AI在药物发现与开发、抗菌药物管理、诊断和监测及公共卫生中的应用与挑战。

主要发现

  • AI可通过揭示临床难以识别的数据模式来构建临床决策支持系统。
  • AI应用覆盖药物发现与开发、抗菌药物管理、诊断和监测等领域。

关键数值与推荐

  • 联合国大会AMR高级别声明设定了人类、动物和环境健康的目标;人类健康关键领域包括新抗生素发现与开发、抗菌药物管理、监测及感染控制与预防。

临床怎么用

  • 感染科医生可关注AI在抗菌药物管理、诊断和监测中的潜在应用以辅助临床决策。

局限性

  • AI实施面临基础设施、专业知识、监管、伦理和政策等挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antimicrobial resistance (AMR) is an intractable problem that has the potential to significantly limit advances in human health. Recently, the UN General Assembly (UNGA) High-Level Statement on AMR defined targets for addressing the impact of resistance on human, animal, and environmental health. For human health, the discovery and development of new antibiotics, antimicrobial stewardship programmes, antimicrobial surveillance, and infection control and prevention are all key areas. Artificial intelligence (AI) is ideally placed to help achieve the UNGA targets via its role in revealing patterns in data that are clinically indiscernible, and using that information to build clinical decision support systems. However, significant barriers remain in terms of necessary infrastructure, know-how, and the implementation of AI approaches. In this Series paper, we consider the potential applications of AI in combatting the AMR problem through drug discovery and development, antimicrobial stewardship, diagnostics, and surveillance, and their use in public health. We then discuss the technical, infrastructure, regulatory, ethical, and policy challenges that affect these domains.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Howard A, Reza N, Green PL, et al. Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery. Lancet Infect Dis. 2025. PMID: 40972630. doi:10.1016/S1473-3099(25)00313-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。